(Last updated : 2023-12-22 11:50:17)
  Takeshi Nagasaka
   Department   Kawasaki Medical School  ,
   Position   Professor
■ BooK
1. 2020/08/25   Immunotherapy for Lynch Syndrome Patients, Lynch Syndrome: Molecular Mechanism and Current Clinical Practice 
■ Journal
1. 2023/01/27 Neutrophil-to-lymphocyte Ratio Prior to Each Chemotherapy Line Predicts Clinical Outcomes in Patients With Unresectable Gastric Cancer 
2. 2022/10/14 Genomically Stable Gastric Cancer Characterized by Hypomethylation in Wnt Signal Cascade 
3. 2022/06/20 Multicenter, single-arm, phase II study of the continuous use of panitumumab in combination with FOLFIRI after FOLFOX for RAS wild-type metastatic colorectal cancer: Exploratory sequential examination of acquired mutations in circulating cell-free DNA 
4. 2022/06 A Trial Protocol of Precision Medicine for Patients with RAS Wild Metastatic Colorectal Cancer Using Liquid Biopsy (RAS-liquid Study): A Prospective, Multicenter Observational Study 
5. 2022/05 Phase 3 trial of sequential versus combination treatment in colorectal cancer: The C-cubed study  Link
Display all(35)
■ Presentation
1. 2023/03/15 Pre-treatment PD-1 lymphocyte ratio in blood may predict clinical outcome of gastric cancer patients under Nivolumab monotherapy (Speech,General) 
2. 2023/01/19 Impact of RAS and BRAF heterogeneity on the efficacy of EGFR blockade in patients with metastatic colorectal cancer.  
3. 2022/10/15 Positioning of cancer genomic medicine in colorectal cancer treatment
Detection of Aberrant DNA Methylation in Circulating Cell Free DNA to Predict Patients with Col-
orectal Cancer (Speech,Panelist at Symposium/Workshop (Applied)) 
4. 2022/02/17 A Phase III trial of sequential versus combination in metastatic colorectal cancer: C-Cubed study (Speech,General) 
5. 2022/02/17 Fluctuating PD-1 ratio in blood may predict clinical outcome of upper gastrointestinal cancer patients under ICI therapy (Poster notice,General) 
Display all(21)